Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 61Stomach Neoplasms 10HER2-positive Breast Cancer 7Colorectal Neoplasms 6Neoplasm Metastasis 5Inflammatory Breast Neoplasms 3Breast Diseases 3Brain Neoplasms 3Pathologic Complete Response 2Neoplasms 2Esophageal Squamous Cell Carcinoma 2Cardiotoxicity 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor, Adult 1Relapsed Pediatric Solid Tumor 1Pancreatic Neoplasms 1Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1Invasive Breast Cancer 1Intestinal Neoplasms 1HER2-positive Metastatic Breast Cancer 1HER2-positive Gastric Cancer 1HER2-positive 1HER2+ Early or Locally Advanced Breast Cancer 1HER2+ Breast Cancer 1HER2 Positive Breast Cancer 1HER-2 Positive Gastric Cancer 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Feasibility 1

Interventions

pyrrolidine 1pirarubicin 1olaparib 1ixabepilone 1exemestane 1eribulin 1apatinib 1Vinorelbine 1Trastuzumab 1Toremifene 1Tamoxifen 1Paclitaxel 1Methotrexate 1Letrozole 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Epirubicin 1Endostatins 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Capecitabine 1Bevacizumab 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Cancer Organoids × Trastuzumab × Clear all
NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Unknown
300 enrolled
Breast

Breast Cancer Organoids

Data powered by HemOnc (CC BY 4.0) Colophon âš¡